Abiopharma

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

USA Rare Earth Commissions Hydrometallurgical Demonstration Facility, Targeting Heavy Rare Earth Oxide Production in Third Quarter 2026

Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

Shock Top Kicks Off the World’s Biggest Summer of Soccer with Shocking Upsets

Electronic Arts Introduces EA Advertising, Launching Brands Directly Into Gameplay and Live Experiences

Lightbridge to Participate in Upcoming Investor and Nuclear Industry Events

Oceaneering to Participate at the 2026 J.P. Morgan Natural Resources Conference

Form 8.3

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/ Changes in Interest of Director

Innovative Industrial Properties Declares Second Quarter 2026 Dividends